RSAD1
Basic information
Region (hg38): 17:50478860-50485974
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RSAD1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 29 | 30 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 29 | 1 | 0 |
Variants in RSAD1
This is a list of pathogenic ClinVar variants found in the RSAD1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-50478900-G-T | not specified | Uncertain significance (Dec 27, 2023) | ||
17-50478901-C-A | not specified | Uncertain significance (Mar 19, 2024) | ||
17-50478922-C-T | not specified | Uncertain significance (Oct 26, 2021) | ||
17-50478952-G-A | not specified | Uncertain significance (Jun 22, 2024) | ||
17-50478963-G-A | not specified | Uncertain significance (Apr 08, 2024) | ||
17-50478982-C-T | not specified | Uncertain significance (Jun 05, 2024) | ||
17-50479000-G-A | not specified | Uncertain significance (Aug 19, 2023) | ||
17-50479009-T-C | not specified | Uncertain significance (Jan 23, 2024) | ||
17-50479681-C-T | not specified | Uncertain significance (May 25, 2022) | ||
17-50479986-T-G | not specified | Uncertain significance (Mar 16, 2024) | ||
17-50480023-C-T | not specified | Uncertain significance (Apr 09, 2024) | ||
17-50482099-T-G | not specified | Uncertain significance (Jul 19, 2023) | ||
17-50482124-C-T | not specified | Uncertain significance (Nov 21, 2023) | ||
17-50482128-C-T | not specified | Uncertain significance (Jan 08, 2024) | ||
17-50482134-C-T | not specified | Uncertain significance (Jan 23, 2024) | ||
17-50482158-T-C | not specified | Uncertain significance (Mar 15, 2024) | ||
17-50482167-C-T | not specified | Uncertain significance (Jun 24, 2022) | ||
17-50482196-G-C | not specified | Uncertain significance (Dec 14, 2021) | ||
17-50482207-G-A | not specified | Uncertain significance (Dec 01, 2022) | ||
17-50482218-C-T | not specified | Uncertain significance (Dec 19, 2022) | ||
17-50482232-G-T | not specified | Uncertain significance (Jan 08, 2024) | ||
17-50482236-C-T | not specified | Likely benign (Nov 30, 2021) | ||
17-50482249-G-T | not specified | Uncertain significance (Oct 03, 2023) | ||
17-50482269-A-G | not specified | Uncertain significance (May 30, 2024) | ||
17-50482361-G-C | not specified | Uncertain significance (Feb 13, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RSAD1 | protein_coding | protein_coding | ENST00000258955 | 9 | 7176 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000217 | 0.905 | 125618 | 2 | 128 | 125748 | 0.000517 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.372 | 269 | 252 | 1.07 | 0.0000152 | 2763 |
Missense in Polyphen | 97 | 86.713 | 1.1186 | 971 | ||
Synonymous | -0.175 | 110 | 108 | 1.02 | 0.00000606 | 986 |
Loss of Function | 1.64 | 12 | 19.9 | 0.604 | 9.50e-7 | 215 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000653 | 0.000653 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000381 | 0.000381 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000348 | 0.000334 |
Middle Eastern | 0.000381 | 0.000381 |
South Asian | 0.00216 | 0.00209 |
Other | 0.000327 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: May be involved in porphyrin cofactor biosynthesis. {ECO:0000250}.;
Recessive Scores
- pRec
- 0.139
Intolerance Scores
- loftool
- 0.721
- rvis_EVS
- 0.26
- rvis_percentile_EVS
- 70.52
Haploinsufficiency Scores
- pHI
- 0.158
- hipred
- N
- hipred_score
- 0.204
- ghis
- 0.483
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.136
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rsad1
- Phenotype
- hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); immune system phenotype; vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- porphyrin-containing compound biosynthetic process;oxidation-reduction process
- Cellular component
- mitochondrion
- Molecular function
- coproporphyrinogen oxidase activity;metal ion binding;4 iron, 4 sulfur cluster binding